Can, E. Et Al. 2022. Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients. Saudi medical journal , vol.43, no.6 , 559-566.

Can, E., Cemil Oğlak, S., Ölmez, F., & Bulut, H., (2022). Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients. Saudi medical journal , vol.43, no.6, 559-566.

Can, Esra Et Al. "Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients," Saudi medical journal , vol.43, no.6, 559-566, 2022

Can, Esra Et Al. "Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients." Saudi medical journal , vol.43, no.6, pp.559-566, 2022

Can, E. Et Al. (2022) . "Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients." Saudi medical journal , vol.43, no.6, pp.559-566.

@article{article, author={Esra Can Et Al. }, title={Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients}, journal={Saudi medical journal}, year=2022, pages={559-566} }